Swedish Orphan Biovit Ord (BIOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BIOVF | GMAB | ASND | ||
| Company | Swedish Orphan Biovit Ord | Genmab A/S ADR | Ascendis Pharma ADR | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 49.0282 | 28.63 | 267.02 | ||
| High | 49.0282 | 29.39 | 267.03 | ||
| Low | 49.0282 | 28.50 | 262.02 | ||
| Latest | 49.0282 | 28.80 | 265.22 | ||
| Change | +1.0282 | -0.20 | -5.23 | ||
| % Change | +2.14% | -0.69% | -1.93% | ||
| Volume | 200 | 4,555,400 | 601,000 | ||
| 20-Day Average Volume | 265 | 2,082,235 | 943,220 | ||
| Previous Close | 48.0000 | 29.00 | 270.45 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 36.4407 | 26.93 | 252.87 | ||
| 20-Day Raw Stochastic | 100.00% | 82.50% | 74.21% | ||
| 20-Day Relative Strength | 75.64 | 60.07 | 59.94 | ||
| Weighted Alpha | N/A | +23.01 | +54.29 | ||
| Today's Opinion | N/A | 8% Sell | 100% Buy | ||
| Previous Opinion | N/A | 8% Sell | 100% Buy | ||
| Last Month's Opinion | N/A | 100% Sell | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +22.97% since 03/31/26 | +2.82% since 07/06/26 | -1.01% since 07/06/26 | ||
| Low | 43.1500 on 04/27/26 | 28.36 on 07/10/26 | 262.02 on 07/13/26 | ||
| High | 49.0282 on 07/09/26 | 29.80 on 07/09/26 | 282.15 on 07/09/26 | ||
| 1-Month | |||||
| %Chg | +2.14% since 06/04/26 | +14.83% since 06/12/26 | +21.63% since 06/12/26 | ||
| Low | 49.0282 on 07/09/26 | 24.08 on 06/16/26 | 218.00 on 06/15/26 | ||
| High | 49.0282 on 07/09/26 | 29.80 on 07/09/26 | 282.15 on 07/09/26 | ||
| 3-Month | |||||
| %Chg | +22.97% since 03/31/26 | +2.13% since 04/13/26 | +6.71% since 04/13/26 | ||
| Low | 43.1500 on 04/27/26 | 23.62 on 06/03/26 | 203.80 on 06/08/26 | ||
| High | 49.0282 on 07/09/26 | 29.80 on 07/09/26 | 282.15 on 07/09/26 | ||
| 6-Month | |||||
| %Chg | +34.01% since 01/07/26 | -14.97% since 01/13/26 | +23.33% since 01/13/26 | ||
| Low | 37.0000 on 01/14/26 | 23.62 on 06/03/26 | 200.68 on 01/20/26 | ||
| High | 49.0282 on 07/09/26 | 35.43 on 01/14/26 | 282.15 on 07/09/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 17,454,038 | 18,082,458 | 16,869,858 | ||
| Shares Outstanding, K | 356,000 | 623,533 | 62,377 | ||
| Annual Sales | 2,885,920,000 | 3,720,000,000 | 814,760,000 | ||
| Annual Net Income | 48,850,000 | 963,000,000 | -258,000,000 | ||
| Last Quarter Sales | 785,930,000 | 896,000,000 | 288,620,000 | ||
| Last Quarter Net Income | 144,190,000 | 53,000,000 | 736,580,000 | ||
| 60-Month Beta | 0.35 | 0.84 | 0.37 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.45 on 04/28/26 | 0.15 on 05/07/26 | 0.32 on 05/07/26 | ||
| Earnings Date | 07/15/26 | 08/06/26 | 08/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 24.87 | 21.42 | 0.00 | ||